Clinical Safety

Researchers have identified that inhibiting the Wee1 protein inadvertently disables a critical switch required for all fast-proliferating cells to begin the DNA replication process. For decades, the pharmaceutical industry has focused on Wee1 as a potential vulnerability for tumors that lack the

Hospitalized cancer patients benefit from a digital safety net that ensures their emotional support and medication needs are met without being overlooked. In the fast-paced environment of a modern oncology unit, the sheer volume of tasks can become overwhelming for even the most experienced

Automated systems download requested analyses directly from internal laboratory information systems to ensure each blood sample follows the correct workflow. This technological integration has become a vital response to the critical shortage of skilled laboratory technicians facing medical

The recent bankruptcy filing of Karyopharm Therapeutics includes a restructuring support agreement and a $55 million debtor-in-possession financing package to maintain clinical operations. This development serves as a sobering reminder of the razor-thin margins for error that currently define the

Practical experiments in ethics-integrated education are essential for developing a workforce capable of navigating the moral complexities of modern genetic engineering. As synthetic biology moves from the theoretical confines of academic research into the rapid-fire pace of industrial

Any project seeking to increase the virulence or transmissibility of a biological agent faces immediate federal funding restrictions under the strict definitions of the new Stopping Policy guidelines. This regulatory pivot, formalized in mid-2026, marks the end of an era where oversight was